Clinical benefit evaluation of drug treatment regimens for advanced lung cancer:based on ASCO-VF and ESMO-MCBS. Pang J, Zhang Y, Wang X, Wu W, et al. Lung Cancer 2024;197:108001.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pang J, Zhang Y, Wang X, Wu W, et al. Clinical benefit evaluation of drug treatment regimens for advanced lung cancer:based on ASCO-VF and ESMO-MCBS. Lung Cancer 2024;197:108001.
PMID: 39476429